India is becoming the go-to hub for pharma giants building future-ready digital and data capabilities, reports businessline.

Analysts say ad margins run as high as 95%, making it one of the most profitable verticals, reports Financial Express.

Triggered by US tariffs, Sensex and Nifty crashed nearly 3%-to-nine-month lows, succumbing to global pressure, wiping ₹16 ...

Their interest is driven by India’s potential as a semiconductor hub and its strategic role in diversifying global supply ...

Casino group Star Entertainment has been saved from financial collapse after signing a $300 million deal with US gaming ...

The country’s biggest asset managers and hedge funds are bracing for a quarter of historically large losses as Wall Street ...

LinkedIn just released its annual list of Top Companies in India, with more than 5,000 global employees — ranking the best ...

Dimon's criticisms of the administration's new trade regime came as investors began betting the Federal Reserve will deliver ...

At $450, the price of Nintendo's Switch 2 doesn't include tariffs — which means it could potentially get more expensive.

The search giant says tweaks like AI Overviews send more traffic to a variety of publishers, but data shows only bigger ...

The sum of around $500 million has reportedly been floated around as an acquisition price for the company, The Information ...

At CinemaCon, Sony Pictures positioned itself as a disruptor with its bombshell announcement to release a four-film Beatles ...